Evidence map›Paper›PMID 35679012›Full record

ArticleJournal of racial and ethnic health disparities2023

HIV Prevention Research Experiences Among Men Who Have Sex With Men and Transgender Persons of Color.

Aparna Alankar, Jamir Tuten, Travis Love, Jennifer Punsal, Shobha Swaminathan, Amesika N Nyaku

Abstract read
In one paragraph

Article in Journal of racial and ethnic health disparities, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aparna AlankarDivision of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
Jamir TutenDivision of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
Travis LoveDivision of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
Jennifer PunsalDivision of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
Shobha SwaminathanDivision of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA.
Amesika N NyakuDivision of Infectious Diseases, Department of Medicine, Rutgers New Jersey Medical School, Newark, USA. amesika.nyaku@rutgers.edu.ORCID 0000-0002-1703-0500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBlack and Latinx MSM and transgender POC disproportionately experience new HIV diagnoses. Determining effective HIV prevention methods requires the inclusion of these communities in research and thorough post-trial experience evaluations. This study sought to evaluate the experiences of Black and Latinx MSM and transgender POC in HIV prevention research and identify facilitators and barriers to continued trials participation.

methodsA survey was developed in partnership with the community engagement team based on emerging themes during research participant check-ins with the team. The survey was built in REDCap and distributed to participants via text message. The survey assessed experiences with the research process time commitments, study responsibilities, compensation, experiences with Truvada®, characteristics of the research study team and site, barriers to continued study participation, willingness to participate in future studies, and overall satisfaction. All statistical analysis was completed in Stata.

resultsForty-four participants were enrolled in the study. Most participants (98%) were satisfied with their experiences in HIV prevention research. Job or school schedules were the most frequently cited barrier to study participation while Truvada® provision and adequate study visit compensation, length, number, and frequency were facilitators. Participants reported that research staff made them feel comfortable when talking about sexual behaviors, alcohol use, mental health, drug use, housing problems, violence in relationships, and legal problems.

conclusionsEvaluating the experiences of key communities in HIV prevention research can help identify barriers and facilitators to clinical trials engagement and improve the design of future trials.

Indexed as

HIV InfectionsSexual and Gender MinoritiesTransgender PersonsEmtricitabine, Tenofovir Disoproxil Fumarate Drug CombinationFemaleHomosexuality, MaleHumansMaleEmtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

Identifiers

PMID35679012
PMCPMC9179221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.